AU2001231865A1 - Amphilic and ionic polymer matrixes and derivatives thereof - Google Patents

Amphilic and ionic polymer matrixes and derivatives thereof

Info

Publication number
AU2001231865A1
AU2001231865A1 AU2001231865A AU3186501A AU2001231865A1 AU 2001231865 A1 AU2001231865 A1 AU 2001231865A1 AU 2001231865 A AU2001231865 A AU 2001231865A AU 3186501 A AU3186501 A AU 3186501A AU 2001231865 A1 AU2001231865 A1 AU 2001231865A1
Authority
AU
Australia
Prior art keywords
amphilic
derivatives
ionic polymer
polymer matrixes
matrixes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001231865A
Inventor
Didier Betbeder
Ignacio De Miguel
Laurent Imbertie
Roger Kravtzoff
Francois Lescure
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biovector Therapeutics SA
Original Assignee
Biovector Therapeutics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0000329A external-priority patent/FR2803526A1/en
Application filed by Biovector Therapeutics SA filed Critical Biovector Therapeutics SA
Publication of AU2001231865A1 publication Critical patent/AU2001231865A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001231865A 2000-01-12 2001-01-10 Amphilic and ionic polymer matrixes and derivatives thereof Abandoned AU2001231865A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0000329 2000-01-12
FR0000329A FR2803526A1 (en) 2000-01-12 2000-01-12 New stable polymeric matrices, useful e.g. for delivery, release and/or stabilization of drugs, comprising charged macromolecular hydrophilic matrix incorporating oppositely charged lipid phase
FR0015126 2000-11-23
FR0015126A FR2803517A1 (en) 2000-01-12 2000-11-23 AMPHIPHILIC AND IONIC PLYMERIC MATRICES AND DERIVATIVES THEREOF
PCT/FR2001/000064 WO2001051090A2 (en) 2000-01-12 2001-01-10 Amphilic and ionic polymer matrixes and derivatives thereof

Publications (1)

Publication Number Publication Date
AU2001231865A1 true AU2001231865A1 (en) 2001-07-24

Family

ID=26212087

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001231865A Abandoned AU2001231865A1 (en) 2000-01-12 2001-01-10 Amphilic and ionic polymer matrixes and derivatives thereof

Country Status (3)

Country Link
AU (1) AU2001231865A1 (en)
FR (1) FR2803517A1 (en)
WO (1) WO2001051090A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0418828A (en) * 2004-06-16 2007-11-13 Cargill Inc cationic cross-linked waxy starch products, a method for producing starch products, and the use in paper products
FR2982262A1 (en) 2011-11-03 2013-05-10 Univ De Droit Et De La Sante De Lille 2 NANOPARTICLE COMPRISING A HEART CHARGED WITH PHOSPHOLIPID AND AN ADSORBED PROTEIN ON SAID HEART-USE FOR THE DELIVERY OF A PROTEIN INTO A CELL

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757768B1 (en) * 1996-12-27 1999-04-02 Biovector Therapeutics Sa HOMEOCHARGE PARTICULATE VECTOR AND PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING THE SAME
ATE291929T1 (en) * 1997-06-13 2005-04-15 Univ Nebraska COMPOSITIONS FOR THE DELIVERY OF BIOLOGICAL ACTIVE INGREDIENTS AND METHODS FOR THEIR PRODUCTION
FR2766706B1 (en) * 1997-07-30 2001-05-25 Biovector Therapeutics Sa STABLE PARTICULATE COMPLEXES OF NEUTRAL OR NEGATIVE GLOBAL LOAD OF MULTILAMELLAR STRUCTURE COMPOSED OF AT LEAST ONE BIOLOGICALLY ACTIVE GLOBALLY ANIONIC SUBSTANCE AND A CATIONIC COMPONENT, THEIR PREPARATION AND USE

Also Published As

Publication number Publication date
FR2803517A1 (en) 2001-07-13
WO2001051090A2 (en) 2001-07-19
WO2001051090A3 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
AU2579301A (en) 1:n protection in an optical terminal
AU2636999A (en) Ion conductive matrixes and their use
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001269140A1 (en) Electrochromic device and corresponding applications
AU5634300A (en) Composition and films thereof
AU2001270819A1 (en) Polymer electrolyte
AU6636700A (en) Low cost broad range loudspeaker and system
AU1540001A (en) Fluorene-perylene copolymers and uses thereof
AUPP939299A0 (en) Polymer gels and methods for their preparation
AU7612000A (en) Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof
AU3246000A (en) Cosmetic or dermapharmaceutical patch
AU2001282854A1 (en) Linear polyphosphazenes and gel polymer electrolytes containing same
AU2002211717A1 (en) Stresscopins and their uses
AU2002235145A1 (en) Stabilization method and composition utilizing an amphoteric polymer
AU6124999A (en) Hydrazinooxoacetamide derivatives and insecticide
AU3479000A (en) Dermatological patch
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001248472A1 (en) Compounds derived from LA2MO2O9 and their use as ionic conductors
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2001253651A1 (en) Dielectric films and related method
AU3719899A (en) Polymers and their uses
AUPR218000A0 (en) Polymer gels and their preparation
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU5247399A (en) Sunblocking polymers and their novel formulations
AU4800299A (en) Pyrazole derivatives and salts thereof